Rosuvastatin

Treatment of hypercholesterolemia Adults and children over 10 years with the primary hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. In homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. Prevention of cardiovascular disorders Prevention of major cardiovascular events in patients who are estimated to have a high risk for the first cardiovascular event, as an adjunct to correction of other risk factors.